Skip to main content
Premium Trial:

Request an Annual Quote

NEWSBRIEF: Applied Biosystems, HTS Biosystems To Develop Functional Proteomics System

NEW YORK, April 29-Applied Biosystems and HTS Biosystems will work together to develop and commercialize a new functional proteomics system, the two companies said today.


In this collaboration, the two companies will work to improve HTS Biosystems' FLEX CHIP, which uses surface plasmon resonance technology to reveal protein binding kinetics. The system is being developed to permit high throughput, label-free protein identification. A few early versions have been placed with HTS collaborators.


ABI, which owns 18 percent of HTS, did not disclose financial details of the arrangement.


The collaboration will "capitalize on Applied Biosystems' expertise in instrument systems development, manufacturing and marketing, and HTS Biosystems' proprietary technology and system integration," said ABI vice president Lauren Linton in a statement.


HTS has established similar collaborations with Mitsubishi Chemical, Protein Sciences Corporation, and others. The company is based in Hopkinton, Mass.


To see the company press release, click here.



The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.